Andere talen STADA Arzneimittel

Aandelen

SAZ

DE0007251803

Vertraagde tijd Xetra Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^EUR	-.--%		-1,95%	-8,87%

2023

Alvotech, Stada krijgen steun van EU-panel voor Stelara Biosimilar

Andere talen

Arzneikonzern Stada wächst - Finanzinvestoren prüfen Ausstieg	14/03
Xbrane has received additional subscription undertakings corresponding to approximately SEK 18.1 million in the Company's rights issue	04/03
Alvotech, Stada Get EU Panel Backing for Stelara Biosimilar	10/11
Calliditas announces filing with UK MHRA for Kinpeygo in IgA nephropathy	03-10-23
STADA and Calliditas announce the filing for full marketing authorization of Kinpeygo® in the EU	28-09-23
Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet	15-08-23
STADA Arzneimittel AG / STADA mit hervorragendem Halbjahresergebnis und ...	15-08-23
STADA and Xbrane weigh options for ranibizumab biosimilar candidate	25-07-23
STADA Arzneimittel AG / STADA baut Consumer-Healthcare-Portfolio in ...	12-07-23
Xbrane announce U.S. FDA filing acceptance for a Lucentis® (ranibizumab) biosimilar candidate	21-06-23
STADA AND XBRANE LAUNCH XIMLUCI AS RANIBIZUMAB BIOSIMILAR IN GERMANY	26-05-23
STADA and Xbrane launch Ximluci® as ranibizumab biosimilar in Germany	26-05-23
STADA AND XBRANE SUPPLY XIMLUCI IN ENGLAND UNDER NHS CONTRACT	26-04-23
STADA and Xbrane supply Ximluci® (ranibizumab) in England under NHS contract	25-04-23
STADA and Xbrane launch ranibizumab to support patient access in Europe	03-04-23
STADA Arzneimittel AG / STADAs nachhaltiger Wachstumskurs führt 2022 zu ...	06-03-23
AFR: STADA Arzneimittel AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG	23-02-23
AFR: STADA Arzneimittel AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG	23-02-23
European Biosimilar Regulatory Updates	08-02-23
Calliditas Receives Conditional Marketing Authorization from UK MHRA for Kinpeygo in IgA nephropathy	02-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen STADA Arzneimittel

Aandelen

SAZ

DE0007251803

Andere talen

Filters